The Latest
-
Earnings & Tariffs
Trump’s tariff effect has dominated medtech earnings calls
While J&J, Abbott and Boston Scientific have all said the White House’s tariff policies will cost them hundreds of millions of dollars, yearly forecasts have remained in place — or even increased.
-
Earnings & Tariffs
Thermo Fisher commits $2B to US manufacturing
The company said the investment will create high-paying jobs and add lab services capacity to its domestic healthcare supply chain.
-
Bausch + Lomb will resume intraocular lens sales weeks after recall
An analysis of the timing of adverse event reports has convinced the company that raw material delivered by a vendor was the source of the problem.
-
Medtronic seeks FDA nod for insulin pump, furthering Abbott collab
Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by Abbott.
-
Boston Scientific CFO Dan Brennan to retire after nearly 30 years with the company
Jon Monson, currently Boston Scientific's senior vice president for investor relations, will replace Brennan beginning June 30.
-
Michael Greiner leaves Avanos over offer under new CEO
Avanos did not offer Greiner a position comparable to the one he held before becoming interim CEO last year.
-
Earnings & Tariffs
Edwards shrugs off tariffs, backs 2025 profit forecast
The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity constraints that have dogged its core business.
Updated 2 hours ago -
Device developers advance AI plans despite Trump uncertainty
Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board members think the agency should keep its leading role.
-
Earnings & Tariffs
Danaher predicts $350M tariff hit, moves to mitigate impact on profits
The company is planning manufacturing footprint changes, supply chain adjustments, surcharges and cost cutting to limit the impact of the tariffs.
-
Earnings & Tariffs
Boston Scientific is ‘very bullish’ on 2025 despite $200M tariff hit
The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of dollars from President Donald Trump’s tariff policies.
-
Earnings & Tariffs
Intuitive lowers profit margin forecast due to tariff pressure
CFO Jamie Samath cautioned that the trade environment, financial pressures on hospitals and macroeconomic risks could extend timelines for robot purchases.
-
Field Medical raises $40M for PFA in ventricular tachycardia
Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart rhythm disorder.
-
Trump tariffs
Who are the United States’ top trading partners?
Explore how over 200 countries’ imports, exports and trade balances with the U.S. last year stack up in this sortable chart.
-
Deep Dive // HHS overhaul
HHS layoffs may be illegal, legal experts say
The federal health department sidestepped normal procedures as it laid off 10,000 employees, according to sources. One union has already filed an internal complaint, while at least two law firms are exploring suits.
-
FDA issues early alert for BD catheters due to leaks
BD recalled certain intravascular catheters tied to reports of 10 serious injuries after finding an increase in cracks from “material fatigue.”